Publications by authors named "Giuseppe Ferrante"

Claim this Profile
L
Left main percutaneous or surgical revascularisation and subsequent risk of transient and persistent renal dysfunction.
Laura Novelli, Jorge Sanz-Sanchez, Alessandra Iaccarino, Angelo Oliva, Riccardo Terzi, Giuseppe Ferrante

Open Heart· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Anaphylactic shock and ST-elevation myocardial infarction following a bee sting: two deadly diseases in a patient with Kounis syndrome.
Guido Del Monaco, Carolina Pascucci, Federica Catapano, Giulio G Stefanini, Giuseppe Ferrante

Front Cardiovasc Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Trissing balloon inflation and percutaneous coronary intervention with drug-coated balloons for the treatment of restenosis of a left main trifurcation lesion.
Francesco Amata, Francesco Paolo Gioia, Gaetano Liccardo, Giancarlo Barberis, Giuseppe Ferrante

Front Cardiovasc Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial.
Giulio Stefanini, Carmelo Carlo-Stella, Francesco Cannata, Mauro Chiarito, Stefano Figliozzi, Giuseppe Ferrante

Cardiovasc Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: 2024 European Society of Cardiology Guidelines on Peripheral Arterial and Aortic Diseases.
Giuseppe Ferrante, Brittany A Bacallao, Francesco Gioia, Guido Del Monaco, Francesco Amata

Eur Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical safety and performance of the third-generation Fantom Encore sirolimus-eluting bioresorbable scaffold: Insights from a single-center study.
Francesco Amata, Massimo Ferraro, Antonio Mangieri, Damiano Regazzoli, Giuseppe Ferrante

Cardiovasc Revasc Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of vulnerable atherosclerotic plaques: the PREVENT trial.
Giuseppe Ferrante, Gianluca Mincione, Antonio Colombo

Lancet· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 European Society of Cardiology Guidelines on Peripheral Arterial and Aortic Diseases.
Giuseppe Ferrante, Brittany A Bacallao, Francesco Gioia, Guido Del Monaco, Francesco Amata

Eur Cardiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
Angelo Oliva, Anna Maria Ioppolo, Mauro Chiarito, Alberto Cremonesi, Alessia Azzano, Giuseppe Ferrante

J Am Heart Assoc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis.
Alessandro Villaschi, Giuseppe Ferrante, Francesco Cannata, Daniela Pini, Matteo Pagnesi

Clin Res Cardiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round.
Alberto Antonicelli, Piergiorgio Muriana, Giovanni Favaro, Giuseppe Mangiameli, Ezio Lanza, Giuseppe Ferrante

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome.
Antonio Landi, Mauro Chiarito, Mattia Branca, Enrico Frigoli, Andrea Gagnor, Giuseppe Ferrante

JACC Cardiovasc Interv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design.
Francesco Cannata, Giulio Stefanini, Carmelo Carlo-Stella, Mauro Chiarito, Stefano Figliozzi, Giuseppe Ferrante

J Cardiovasc Med (Hagerstown)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention.
Damiano Baldassarre, Licia Iacoviello, Roberta Baetta, Maria Carla Roncaglioni, Gianluigi Condorelli, Giuseppe Ferrante

BMJ Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial.
Mauro Chiarito, Jorge Sanz-Sanchez, Raffaele Piccolo, Francesco Condello, Gaetano Liccardo, Giuseppe Ferrante

Cardiovasc Diabetol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Distal Transradial Access in Acute Coronary SyndromesShould We Give the First Try?
Giuseppe Ferrante, Sunil V Rao, Marco Valgimigli

JACC Cardiovasc Interv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention: A Meta-Analysis of Randomized Trials.
Giuseppe Ferrante, Francesco Condello, Sunil V Rao, Matteo Maurina, Sanjit Jolly

JACC Cardiovasc Interv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Effects of Dual Antiplatelet Therapy or Aspirin Monotherapy after Acute Minor Ischemic Stroke or Transient Ischemic Attack, a Meta-Analysis.
Francesco Condello, Gaetano Liccardo, Giuseppe Ferrante

Curr Pharm Des· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients.
Carlo A Pivato, Bernhard Reimers, Luca Testa, Andrea Pacchioni, Carlo Briguori, Giuseppe Ferrante

J Am Heart Assoc· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials.
Guglielmo Gallone, Luca Baldetti, Filippo Angelini, Andrea Saglietto, Matteo Bellettini, Giuseppe Ferrante

Can J Cardiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MitraClip Treatment for Severe Mitral Regurgitation Due to Chordae Rupture Following Impella CP Support in a Patient With Severe Aortic Stenosis.
Carlo Andrea Pivato, Giuseppe Ferrante, Martina Briani, Jorge Sanz Sanchez, Bernhard Reimers

Cardiovasc Revasc Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense.
Gianluigi Condorelli, Giuseppe Ferrante

J Am Coll Cardiol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Percutaneous mitral valve repair in acute mitral regurgitation].
Francesco Cannata, Jorge Sanz-Sánchez, Ottavia Cozzi, Martina Briani, Letizia Bertoldi, Giuseppe Ferrante

G Ital Cardiol (Rome)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis.
Francesco Condello, Matteo Sturla, Bernhard Reimers, Gaetano Liccardo, Giulio G Stefanini, Giuseppe Ferrante

Eur Cardiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual antiplatelet therapy duration after percutaneous coronary intervention with drug-eluting stents: how short can we go?
Fausto Roccasalva, Giuseppe Ferrante

Minerva Cardioangiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis